Show
Sort by
-
Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment
-
- Journal Article
- A1
- open access
Heterotelechelic polymer prodrug nanoparticles : adaptability to different drug combinations and influence of the dual functionalization on the cytotoxicity
-
Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis : a multi-institutional cohort from PSOGI and BIG RENAPE groups
-
Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma
-
A linear synthesis of gemcitabine
-
Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis
-
The synthesis of gemcitabine
-
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology
-
Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma
-
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)